fresh blood and stored components in children cardiac surgery

Comparison of the effect of receiving fresh blood or stored blood components on incidence of bleeding and hemodynamic changes in children with congenital heart diseases candidate for surgery

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20171104037209N2

Enrollment

Registered

2018-03-12

Start date

2018-03-21

Completion date

Unknown

Last updated

2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital Heart Disease. Congenital malformation of heart, unspecified

Interventions

Intervention 1: Intervention group: Receiving fresh blood during operation. Intervention 2: Intervention group: Receiving stored components during operation.

Eligibility

Sex/Gender

All

Age

1 Months to 5 Years

Inclusion criteria

Inclusion criteria: Having age between 1 month- 5 years Having indication for cardiac surgery due to acyanotic congenial heart disease parent's willingness

Exclusion criteria

Exclusion criteria: Sensitivity to Protamine

Design outcomes

Primary

Measure	Time frame
Bleeding volume after operation. Timepoint: After operation in Intensive Care Unit. Method of measurement: Measuring drainage volume.;Mean Arterial Pressure. Timepoint: After artery line insertion, during operation, in Intensive Care Unit. Method of measurement: Using blood pressure machine.;Hemoglobin level. Timepoint: After artery line insertion, during operation, in Intensive Care Unit. Method of measurement: Spectrophotometer device.;Hematocrit. Timepoint: After artery line insertion, during operation, in Intensive Care Unit. Method of measurement: Spectrophotometer device.	—

Measure

Time frame

Bleeding volume after operation. Timepoint: After operation in Intensive Care Unit. Method of measurement: Measuring drainage volume.;Mean Arterial Pressure. Timepoint: After artery line insertion, during operation, in Intensive Care Unit. Method of measurement: Using blood pressure machine.;Hemoglobin level. Timepoint: After artery line insertion, during operation, in Intensive Care Unit. Method of measurement: Spectrophotometer device.;Hematocrit. Timepoint: After artery line insertion, during operation, in Intensive Care Unit. Method of measurement: Spectrophotometer device.

—

Secondary

Measure	Time frame
Mortality. Timepoint: After operation. Method of measurement: observation.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAthar Zandi

Esfahan University of Medical Sciences

Athar.zandi@yahoo.com+98 31 3668 0048

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026